The first health wedge.
The surge is here now. We build de-identified cohorts from verified real-world data and reach them on streaming, so your brand is the one a patient already knows when the refill decision comes.
Healthcare, next
Same engine.Two fights.
The diagnostic we run for high-spend law firms transfers cleanly to person-first health brands. The GLP-1 surge moved a generation of patients into the market at once, and one brand will own the answer they get when they ask the machine who to trust. We are building this lane next. Get on the list before your category fills.
Check my marketWhat carries over
Same engine. Same read.The line we hold is higher.
- CohortAudiences built de-identified, never one person
- Real-worldCohorts built from verified real-world health data
- One seatOne brand seated per category, per market, never two rivals
- StreamingReach built for premium streaming, never a guaranteed patient count
Audiences are de-identified. We never target a person and never promise a patient count.
The shared problem
Metabolic brands all sound the same.
Same promise. Same stock smile. Same hopeful headline. Patients are searching for who to believe, and most brands blend into one another, the same way most law firms buy the same click and disappear. We find the open lane, build a brand a patient remembers, and carry it where they spend their evenings. Marketing economics, never clinical advice. That line we do not cross.
Live in legal first, health right behind.
The same Earn, Build, Carry arc runs in both fights. Legal is live today. Health is the next lane we open, and we are taking names for the brands who want first claim.
See the engine running in legal →
One seat per market.Then it's closed.
Same trust bar as legal, higher stakes. We'll arm one brand per category per market, never two rivals. This lane is staging now. Check whether yours can be first.
Check my market